Back to Market Feed

Product Information

TERIPARATIDE 560 MCG/2.24 ML PEN is a generic product labeled by Alvogen Inc., priced at $494.8050 per ML under NDC 47781065289. Its NADAC has been published 210 times since Aug 17, 2022.

FDA first approved this application on Oct 4, 2019.

TERIPARATIDE 560 MCG/2.24 ML PEN

teriparatide
$494.8050per ML

Strength

250 ug/mL

Manufacturer

Alvogen Inc.

NDC

47781065289

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

TERIPARATIDE

Approval Type

New Drug (NDA)

FDA Application

NDA211939

FDA Approved

10/4/2019

On Market Since

11/14/2019

Pharmacological Classes

Parathyroid Hormone Analog
Parathyroid Hormone

Price Statistics

The NADAC for TERIPARATIDE 560 MCG/2.24 ML PEN has been published 210 times since Aug 17, 2022, and over the history we have for it it has declined 50.4%. The table below summarizes its recorded NADAC range and movement.

Current price$494.8050 per ML
All-time high$1007.5345 (Oct 16, 2024)
All-time low$494.8050 (Aug 19, 2026)
52-week high$846.0749
52-week low$494.8050
Median price$992.9227
Average price$903.8489
Largest weekly change-20.7% (Oct 22, 2025)
Weeks tracked210
Tracking sinceAug 17, 2022

Price History

1W

-5.0%

1M

-5.0%

3M

-7.5%

6M

-20.8%

1Y

-41.5%

3Y

-50.5%

5Y

N/A

All

-50.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

BONSITY 560 MCG/2.24 ML PEN
Generic
47781085289•Alvogen Inc.
$494.8050

Related Drugs

Same classification

TERIPARATIDE 560 MCG/2.24 ML PEN
Generic
00093110616•Teva Pharmaceuticals USA Inc.
$494.8050
per ML
TERIPARATIDE 560 MCG/2.24 ML PEN
Generic
00548231100•Amphastar Pharmaceuticals, Inc.
$494.8050
per ML
TERIPARATIDE 560 MCG/2.24 ML PEN
Generic
60505618800•Apotex Corp.
$494.8050
per ML
TERIPARATIDE 560 MCG/2.24 ML PEN
Generic
66993049528•Prasco Laboratories
$494.8050
per ML
TERIPARATIDE 560 MCG/2.24 ML PEN
Generic
66993098928•Prasco Laboratories
$494.8050
per ML

Frequently asked questions

What is the NADAC price of TERIPARATIDE 560 MCG/2.24 ML PEN?

The current National Average Drug Acquisition Cost (NADAC) for TERIPARATIDE 560 MCG/2.24 ML PEN, manufactured by Alvogen Inc., is $494.8050 per ML (NDC 47781065289), effective Aug 19, 2026.

How has the price of TERIPARATIDE 560 MCG/2.24 ML PEN changed over time?

Over the history we have for it, the NADAC for TERIPARATIDE 560 MCG/2.24 ML PEN has declined 50.4%. It has been tracked across 210 weekly CMS publications since Aug 17, 2022.

What are the highest and lowest recorded NADAC prices for TERIPARATIDE 560 MCG/2.24 ML PEN?

Since Aug 17, 2022, the NADAC for TERIPARATIDE 560 MCG/2.24 ML PEN has ranged from a low of $494.8050 (Aug 19, 2026) to a high of $1007.5345 (Oct 16, 2024), with a median of $992.9227 per ML.

Are there cheaper alternatives to TERIPARATIDE 560 MCG/2.24 ML PEN?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TERIPARATIDE 560 MCG/2.24 ML PEN in a comparable dosage form, but none are currently priced below it.

Who manufactures TERIPARATIDE 560 MCG/2.24 ML PEN?

TERIPARATIDE 560 MCG/2.24 ML PEN (NDC 47781065289) is labeled by Alvogen Inc., and CMS classifies it as a generic product.